Pharmacopsychiatry 2011; 44(1): 33-48
DOI: 10.1055/s-0030-1267942
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Ketamine-Induced Disruption of Verbal Self-Monitoring Linked to Superior Temporal Activation

J. M. Stone1 , 2 , K. M. Abel3 , M.P.G. Allin1 , N. van Haren4 , K. Matsumoto5 , P. K. McGuire1 , C. H. Y. Fu1
  • 1Institute of Psychiatry, King's College London, UK
  • 2Centre for Mental Health, Imperial College London, Hammersmith Hospital, London, UK
  • 3Department of Psychiatry and Behavioural Sciences, Manchester University, Manchester, UK
  • 4University Medical Center Utrecht, The Netherlands
  • 5Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan
Further Information

Publication History

received 11.05.2010 revised 26.08.2010

accepted 30.08.2010

Publication Date:
13 December 2010 (online)

Abstract

Introduction: Misattribution of distorted self-generated speech in patients with schizophrenia has been associated with increased lateral temporal activation. As a pharmacological model of schizophrenia, we tested whether ketamine would induce the same effects in healthy individuals.

Methods: Participants were 8 healthy male volunteers who were naïve to ketamine (mean age: 28 years). Ketamine (0.23 mg/kg bolus followed by 0.64 mg/kg/h) and placebo infusions were administered in a double-blind, randomised order, during 2 functional magnetic resonance imaging (fMRI) sessions. Each fMRI session consisted of a verbal self-monitoring task in which auditory feedback was experimentally modified.

Results: Ketamine was associated with psychotic and dissociative symptoms. Participants made more misattributions of distorted self-generated speech (p<0.02) during the ketamine infusion. Ketamine led to reduced activation in the left superior temporal cortex during self-distorted speech, regardless of whether the speech was identified correctly or not, as compared to the placebo infusion. Misidentification of speech that had been distorted was not associated with any increase in brain activation in during the placebo infusion, however ketamine-induced misattributions were associated with a relative increase in left superior temporal cortex activation.

Discussion: These data are consistent with the notion that self-monitoring impairments underlie psychotic symptoms and suggest that N-methyl-D-aspartate (NMDA) receptor dysfunction may mediate self-monitoring deficits and psychotic phenomena in schizophrenia.

References

  • 1 Abel KM, Allin MP, Kucharska-Pietura K. et al . Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study.  Neuroreport. 2003;  14 387-391
  • 2 Allen PP, Johns LC, Fu CH. et al . Misattribution of external speech in patients with hallucinations and delusions.  Schizophr Res. 2004;  69 277-287
  • 3 Brammer MJ, Bullmore ET, Simmons A. et al . Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach.  Magn Reson Imaging. 1997;  15 763-770
  • 4 Bremner JD, Krystal JH, Putnam FW. et al . Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS).  J Trauma Stress. 1998;  11 125-136
  • 5 Bullmore E, Long C, Suckling J. et al . Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains.  Hum Brain Mapp. 2001;  12 61-78
  • 6 Bullmore ET, Suckling J, Overmeyer S. et al . Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain.  IEEE Trans Med Imaging. 1999;  18 32-42
  • 7 Bullmore ET, Brammer MJ, Rabe-Hesketh S. et al . Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI.  Hum Brain Mapp. 1999;  7 38-48
  • 8 Cahill C. Psychotic experiences induced in deluded patients using distorted auditory feedback.  Cognit Neuropsychiatry. 1996;  1 201-211
  • 9 Corlett PR, Honey GD, Fletcher PC. From prediction error to psychosis: ketamine as a pharmacological model of delusions.  J Psychopharmacol. 2007;  21 238-252
  • 10 Costafreda SG, Brebion G, Allen P. et al . Affective modulation of external misattribution bias in source monitoring in schizophrenia.  Psychol Med. 2008;  38 821-824
  • 11 Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders.  Schizophr Bull. 1978;  4 636-640
  • 12 Frith CD, Done DJ. Towards a neuropsychology of schizophrenia.  Br J Psychiatry. 1988;  153 437-443
  • 13 Fu CH, Vythelingum GN, Brammer MJ. et al . An fMRI study of verbal self-monitoring: neural correlates of auditory verbal feedback.  Cereb Cortex. 2006;  16 969-977
  • 14 Fu CH, Brammer MJ, Yaguez L. et al . Increased superior temporal activation associated with external misattributions of self-generated speech in schizophrenia.  Schizophr Res. 2008;  100 361-363
  • 15 Geisslinger G, Hering W, Thomann P. et al . Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.  Br J Anaesth. 1993;  70 666-671
  • 16 Honey GD, O’Loughlin C, Turner DC. et al . The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia.  Neuropsychopharmacology. 2006;  31 413-423
  • 17 Honey GD, Honey RA, O’Loughlin C. et al . Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study.  Cereb Cortex. 2005;  15 749-759
  • 18 Honey GD, Corlett PR, Absalom AR. et al . Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.  J Neurosci. 2008;  28 6295-6303
  • 19 Honey RA, Honey GD, O’Loughlin C. et al . Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.  Neuropsychopharmacology. 2004;  29 1203-1214
  • 20 Johns LC, McGuire PK. Verbal self-monitoring and auditory hallucinations in schizophrenia.  Lancet. 1999;  353 469-470
  • 21 Johns LC, Rossell S, Frith C. et al . Verbal self-monitoring and auditory verbal hallucinations in patients with schizophrenia.  Psychol Med. 2001;  31 705-715
  • 22 Keefe RS, Arnold MC, Bayen UJ. et al . Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis.  Psychol Med. 1999;  29 903-914
  • 23 Kim JS, Kornhuber HH, Schmid-Burgk W. et al . Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.  Neurosci Lett. 1980;  20 379-382
  • 24 Krystal JH, Karper LP, Seibyl JP. et al . Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.  Arch Gen Psychiatry. 1994;  51 199-214
  • 25 Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia.  Nat Rev Neurosci. 2005;  6 312-324
  • 26 Mechelli A, Allen P, Amaro Jr E. et al . Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations.  Hum Brain Mapp. 2007;  28 1213-1222
  • 27 Moghaddam B, Adams B, Verma A. et al . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.  J Neurosci. 1997;  17 2921-2927
  • 28 Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia.  Arch Gen Psychiatry. 1995;  52 998-1007
  • 29 Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia.  J Psychiatr Res. 1999;  33 523-533
  • 30 Pomarol-Clotet E, Honey GD, Murray GK. et al . Psychological effects of ketamine in healthy volunteers. Phenomenological study.  Br J Psychiatry. 2006;  189 173-179
  • 31 Ryder S, Way WL, Trevor AJ. Comparative pharmacology of the optical isomers of ketamine in mice.  Eur J Pharmacol. 1978;  49 15-23
  • 32 Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain.. New York: Thieme; 1988
  • 33 Vollenweider FX, Leenders KL, Oye I. et al . Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).  Eur Neuropsychopharmacol. 1997;  7 25-38
  • 34 Wolpert DM, Ghahramani Z, Jordan MI. An internal model for sensorimotor integration.  Science. 1995;  269 1880-1882

Notice:

This article was changed according to the following erratum on January 27th 2011.

Erratum:

The name of the third author should be Allin.

Correspondence

C. H. Y. Fu

Institute of Psychiatry

103 Denmark Hill, P074

SE5 8AF London

UK

Phone: +44/(0)207/848 5350

Fax: +44/(0)207/848 0783

Email: cynthia.fu@kcl.ac.uk

    >